You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Drug Maker Mallinckrodt Reaches $1.6B Settlement for Role in Opioid Crisis

HeadlineFeb 26, 2020

A British pharmaceutical company has reached a tentative deal to settle hundreds of U.S. lawsuits over its role in fueling the opioid crisis. The generic drug manufacturer Mallinckrodt says the $1.6 billion deal has the support of attorneys general from 47 U.S. states and territories. Federal data show the company was a top producer of highly addictive prescription pain medication at the peak of the opioid crisis, shipping some 2.3 billion pills over an eight-year period beginning in 2006.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation